SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India informs about change in management

22 Apr 2026 Evaluate
Abbott India has informed about following outcome of the Board Meeting held today i.e., April 22, 2026. Anisha Motwani (DIN: 06943493), Independent Director, will be completing her second term as an Independent Director of the Company on April 24, 2026. Accordingly, she ceases to be the Director of the Company with effect from the close of business hours on April 24, 2026. Details pursuant to SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 (SEBI Circular), is enclosed as Annexure; Appointment of Neeraj Jain (DIN: 00348591) as an Additional Director designated as an Independent Director, with effect from April 25, 2026; etc.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

25198.45 -224.05 (-0.88%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×